🔎 Trials Near Me

홈 › 유방암 › 워싱턴 D.C.

워싱턴 D.C.의 유방암 임상 시험

유방암 관련 연구 28개가 워싱턴 D.C. 내 여러 지역에서 참여자를 모집하고 있습니다.

워싱턴 D.C.의 도시

공식 연구 텍스트(영어)

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

  • Georgetown University Medical Center, Washington D.C.
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT06982521

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

  • Georgetown University Lombardi Cancer Center, Washington D.C.
피험자 모집 중3상
18세 ~ 100세 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT05827081

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • MedStar Georgetown University Hospital, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
피험자 모집 중관찰 연구건강한 지원자 환영
40세 ~ 75세 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT05334069

Older Breast Cancer Patients: Risk for Cognitive Decline

  • Georgetown University, Washington D.C.
피험자 모집 중관찰 연구건강한 지원자 환영
60세 ~ 105세 · 여성 · 2026. 9. 28. 업데이트됨 · NCT03451383

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

  • The George Washington Medical facility Associates, Washington D.C.
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07007559

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

  • MedStar Washington Hospital Center, Washington D.C.
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07174336

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

  • Georgetown Uni Hospital, Washington D.C.
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT05894239

Identifying Patterns in the Breath of Individuals With Breast Cancer

  • GW Comprehensive Breast Center, Washington D.C.
피험자 모집 중관찰 연구건강한 지원자 환영
40세 ~ 74세 · 여성 · 2026. 9. 18. 업데이트됨 · NCT06512350

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

  • Georgetown University Medical Center, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
  • Sibley Memorial Hospital, Washington D.C.
  • 외 1개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT06492616

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

  • MedStar Heart & Vascular Institute (MHVI) - MedStar Washington Hospital Center, Washington D.C.
피험자 모집 중1상
18세 ~ 55세 · 여성 · 2026. 9. 9. 업데이트됨 · NCT07310420

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

  • Georgetown University, Washington D.C.
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT05315700

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

  • Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
  • MedStar Georgetown University Hospital, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
  • 외 2개
피험자 모집 중3상
18세 ~ 60세 · 여성 · 2026. 9. 2. 업데이트됨 · NCT05879926

TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd

  • Georgetown University Medical Center, Washington D.C.
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 8. 26. 업데이트됨 · NCT06533826

Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming

  • Sibley Memorial Hospital, Washington D.C.
피험자 모집 중
18세 이상 · 여성 · 2026. 8. 21. 업데이트됨 · NCT06536881

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

  • Sibley Memorial Hospital, Washington D.C.
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT06500481

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

  • Johns Hopkins Medicine - Kimmel Cancer Center-Sibley Memorial Hospital, Washington D.C.
피험자 모집 중3상
18세 ~ 100세 · 모든 성별 · 2026. 8. 6. 업데이트됨 · NCT05232916

E-Mindfulness Approaches for Living After Breast Cancer

  • Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
  • MedStar Georgetown University Hospital, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
피험자 모집 중3상
18세 ~ 50세 · 모든 성별 · 2026. 8. 4. 업데이트됨 · NCT06748222

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

  • Georgetown University Medical Center, Washington D.C.
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 5. 6. 업데이트됨 · NCT01042379

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

  • MedStar Washington Hospital Center, Washington D.C.
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 5. 6. 업데이트됨 · NCT07062965

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

  • MedStar Georgetown University Hospital, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
  • George Washington University Medical Center, Washington D.C.
피험자 모집 중3상
50세 ~ 70세 · 모든 성별 · 2026. 4. 23. 업데이트됨 · NCT04852887

Cancer Experience Registry (CER) for Cancer Patients and Caregivers

  • Cancer Support Community Research & Training Institute, Washington D.C.
피험자 모집 중관찰 연구건강한 지원자 환영
18세 이상 · 모든 성별 · 2026. 4. 23. 업데이트됨 · NCT02333604

Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer

  • Georgetown University, Washington D.C.
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 4. 9. 업데이트됨 · NCT04841148

Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)

  • George Washington-Medical Faculty Associates, Washington D.C.
피험자 모집 중2상
21세 이상 · 모든 성별 · 2026. 3. 3. 업데이트됨 · NCT06806930

The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer

  • Sibley Memorial Hospital, Washington D.C.
피험자 모집 중
18세 이상 · 여성 · 2026. 2. 23. 업데이트됨 · NCT05780814

Study in Patients With Breast Cancer Leptomeningeal Metastasis

  • Sibley Memorial Hospital, Washington D.C.
피험자 모집 중관찰 연구
18 Weeks · 모든 성별 · 2025. 11. 28. 업데이트됨 · NCT06638294

The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI

  • Georgetown University, Washington D.C.
피험자 모집 중
18세 ~ 74세 · 여성 · 2025. 9. 30. 업데이트됨 · NCT06892275

CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing

  • Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
피험자 모집 중건강한 지원자 환영
18세 이상 · 여성 · 2025. 8. 28. 업데이트됨 · NCT05130606

CtDNA Based MRD Testing for NAC Monitoring in TNBC

  • George Washington University, Washington D.C.
피험자 모집 중관찰 연구
18세 이상 · 여성 · 2025. 1. 7. 업데이트됨 · NCT06230185

ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.